Acetaminophen/hydrocodone Sales Data
| Rank 57 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows acetaminophen/hydrocodone U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 57 ( 2) |
$264,814 | 6.67% | 9,155 | 1.25% |
| Q3 2013 | 59 ( 1) |
$248,261 | -1.27% | 9,042 | -5.74% |
| Q2 2013 | 58 | $251,449 | -0.20% | 9,593 | -4.30% |
| Q1 2013 | 58 (1) |
$251,964 | 1.58% | 10,024 | -2.92% |
| Q4 2012 | 57 (12) |
$248,050 | 9.57% | 10,325 | 5.35% |
| Q3 2012 | 69 (14) |
$226,379 | 18.96% | 9,801 | 2.85% |
| Q2 2012 | 83 (5) |
$190,298 | 2.66% | 9,529 | 1.59% |
| Q1 2012 | 88 (1) |
$185,374 | 0.09% | 9,380 | -0.89% |
| Q4 2011 | 87 (9) |
$185,206 | 16.09% | 9,464 | 0.72% |
| Q3 2011 | 96 (2) |
$159,532 | -0.90% | 9,396 | -2.04% |
| Q2 2011 | 98 ( ) |
$160,975 | n/a | 9,592 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
